Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03906227Not ApplicableTerminated
Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis
ANCA Associated Vasculitis
PrincipalinvestigatorStart date: 2019-06-28
NCT01845428Phase 1Completed
Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome
HyperlipidemiaNephrotic Syndrome
PrincipalinvestigatorStart date: 2012-05-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of North Carolina, Chapel Hill

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rebecca J Brown, M.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
12 trials

Shared therapeutic areas:

HyperlipidemiasNephrotic Syndrome

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score20%

Kevin Volpp, MD, PhD

University of Pennsylvania

Related
12 trials

Shared therapeutic areas:

Hyperlipidemias
Similarity Score10%

Ginger Nicol, MD

Washington University School of Medicine

Related
7 trials

Shared therapeutic areas:

Hyperlipidemias
Similarity Score10%

Russell J de Souza, ScD, RD

Department of Epidemiology and Biostatistics, McMaster University and Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital

Related
5 trials

Shared therapeutic areas:

Hyperlipidemias
Similarity Score10%

Robert D Shamburek, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
7 trials

Shared therapeutic areas:

Hyperlipidemias
Similarity Score10%

Junzhou Fu, MD

Department of Nephrology,1st People's Hospital of Guangzhou

Related
2 trials

Shared therapeutic areas:

Nephrotic Syndrome
Similarity Score10%

You-Cheng Mr Shen, Ph.D.

Chung Shan Medical University

Related
7 trials

Shared therapeutic areas:

Hyperlipidemias
Similarity Score10%

Bo Yu, MD,PhD

The Second Affiliated Hospital of Harbin Medical University

Related
7 trials

Shared therapeutic areas:

Hyperlipidemias
Similarity Score10%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

Hyperlipidemias
Similarity Score10%

Wei Zhao, Ph.D

Shandong University

Related
10 trials

Shared therapeutic areas:

Nephrotic Syndrome
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03906227Not ApplicablePrincipalInvestigator

Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis

ANCA Associated Vasculitis
Terminated
NCT01845428Phase 1PrincipalInvestigator

Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome

HyperlipidemiaNephrotic Syndrome
Completed

All 2 trials loaded